Antibe Therapeutics Inc.
ATBPF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19,475 | -$25,060 | -$24,734 | -$19,342 |
| Dep. & Amort. | $0 | $99 | $478 | $572 |
| Deferred Tax | $0 | $0 | $452 | $1,600 |
| Stock-Based Comp. | $2,808 | $5,521 | $3,989 | $3,376 |
| Change in WC | $28 | $2,502 | $19,659 | $1,691 |
| Other Non-Cash | $334 | $18 | $52 | $168 |
| Operating Cash Flow | -$16,305 | -$16,920 | -$105 | -$11,935 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9 | -$9 | $0 | -$2 |
| Net Acquisitions | $0 | -$236 | $0 | $0 |
| Inv. Purchases | -$48,436 | -$19,975 | $0 | $0 |
| Inv. Sales/Matur. | $36,299 | $20 | $0 | $100 |
| Other Inv. Act. | $319 | -$20 | -$264 | -$560 |
| Investing Cash Flow | -$11,827 | -$20,220 | -$264 | $98 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$79 | -$152 | -$2,411 | -$190 |
| Stock Issued | $0 | $128 | $69,115 | $8,050 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $159 | $126 | -$544 | $4,143 |
| Financing Cash Flow | $80 | -$26 | $66,160 | $12,003 |
| Forex Effect | $0 | $0 | $0 | $23 |
| Net Chg. in Cash | -$28,052 | -$37,166 | $65,791 | $189 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $34,807 | $71,973 | $6,182 | $5,993 |
| End Cash | $6,755 | $34,807 | $71,973 | $6,182 |
| Free Cash Flow | -$16,314 | -$16,929 | -$105 | -$11,937 |